High Trop-2 Linked to Better Survival in Early TNBC
High Trop-2 membrane expression in early-stage triple-negative breast cancer is an independent prognostic marker associated with improved survival outcomes, according ...
High Trop-2 membrane expression in early-stage triple-negative breast cancer is an independent prognostic marker associated with improved survival outcomes, according ...
A retrospective cohort study of 735 emergency department patients with acute ischemic stroke found that lower HALP scores, a composite ...
A retrospective cohort study of 2,486 major trauma patients in South Korea found that severe admission ionized hypocalcemia below 1.0 ...
A secondary analysis of 785 patients from the phase III EXPAND trial found that coronary artery calcification scored on baseline ...
A resting-state fMRI and machine learning study identified six brain regions whose individualized dysconnectivity patterns distinguished subacute back pain patients ...
An integrative analysis finds the splicing protein LSM5 over-expressed across cancers and linked to cell-cycle progression, migration and shorter survival ...
A retrospective study of 207 patients found that low Ki-67 expression below 50 percent was associated with significantly shorter disease-free ...
A two-center study with external validation finds that admission lactate is associated with 30-day mortality after severe traumatic brain injury ...
Researchers have developed and validated a 45-gene transcriptomic signature, Met-Score, that quantifies metastatic competence in primary prostate tumors and predicts ...
A Japanese study of 105 patients with high-risk head and neck cancer found that losing five percent or more of ...
In the realm of hematological malignancies, the quest for prognostic markers that can predict patient outcomes is of paramount importance. ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.